Recombinant Factor VIIa Reduces Bleeding Risk in Patients on Platelet Aggregation Inhibitors Immediately prior to Renal Transplantation – A Retrospective Analysis

Publisher： Karger

E-ISSN： 1423-0399|78|2|135-139

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.78, Iss.2, 2007-02, pp. : 135-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Bleeding in Patients with Platelet Disorders: Is There a Place for Recombinant Factor VIIa?

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 37-40

Karger

Access to resources Recommend Favorite

More on: platelet count and the Use of Recombinant Factor VIIa for the treatment of Bleeding Complications after Hematopoietic Stem Cell Transplantation

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 288-288

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful treatment of severe bleeding with recombinant factor VIIa after kidney transplantation

By Gielen-Wijffels S.   Mook W.   Geest S.   Ramsay G.  

Intensive Care Medicine, Vol. 30, Iss. 6, 2004-06 ,pp. : 1232-1234

Springer Publishing Company

Access to resources Recommend Favorite

The Use of Recombinant Factor VIIa in Controlling Surgical Bleeding in Non-Haemophiliac Patients

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 41-46

Karger

Access to resources Recommend Favorite

Pharmacoeconomic analysis of recombinant factor VIIa versus APCC in the treatment of minor-to-moderate bleeds in hemophilia patients with inhibitors

By Joshi Ashish V.   Stephens Jennifer M.   Munro Vicki   Mathew Prasad   Botteman Marc F.  

Current Medical Research and Opinion, Vol. 22, Iss. 1, 2006-01 ,pp. : 23-31

Informa Healthcare

Access to resources Recommend Favorite